| Year |
Citation |
Score |
| 2023 |
Galili U. Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies. Frontiers in Molecular Biosciences. 10: 1209974. PMID 37449060 DOI: 10.3389/fmolb.2023.1209974 |
0.408 |
|
| 2022 |
Galili U. Paleo-immunology of human anti-carbohydrate antibodies preventing primate extinctions. Immunology. PMID 36161654 DOI: 10.1111/imm.13582 |
0.472 |
|
| 2021 |
Galili U. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies. Frontiers in Molecular Biosciences. 8: 746883. PMID 34805272 DOI: 10.3389/fmolb.2021.746883 |
0.337 |
|
| 2020 |
Galili U. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection. International Journal of Molecular Sciences. 21. PMID 32933166 DOI: 10.3390/ijms21186702 |
0.407 |
|
| 2020 |
Galili U. Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections. Antibodies (Basel, Switzerland). 9. PMID 32580274 DOI: 10.3390/antib9020025 |
0.464 |
|
| 2019 |
Galili U. Evolution in primates by "Catastrophic-selection" interplay between enveloped virus epidemics, mutated genes of enzymes synthesizing carbohydrate antigens, and natural anti-carbohydrate antibodies. American Journal of Physical Anthropology. 168: 352-363. PMID 30578545 DOI: 10.1002/ajpa.23745 |
0.421 |
|
| 2017 |
Stone KR, Walgenbach A, Galili U. INDUCED REMODELING OF PORCINE TENDONS TO HUMAN ANTERIOR CRUCIATE LIGAMENTS BY α-GAL EPITOPE REMOVAL AND PARTIAL CROSSLINKING. Tissue Engineering. Part B, Reviews. PMID 28068870 DOI: 10.1089/ten.TEB.2016.0332 |
0.327 |
|
| 2016 |
Galili U. Natural anticarbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics? Glycobiology. PMID 27567275 DOI: 10.1093/glycob/cww088 |
0.502 |
|
| 2015 |
Kristian SA, Hwang JH, Hall B, Leire E, Iacomini J, Old R, Galili U, Roberts C, Mullis KB, Westby M, Nizet V. Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer. Journal of Molecular Medicine (Berlin, Germany). 93: 619-31. PMID 25940316 DOI: 10.1007/S00109-015-1280-4 |
0.433 |
|
| 2013 |
Galili U. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates. Xenotransplantation. 20: 267-76. PMID 23968556 DOI: 10.1111/xen.12051 |
0.466 |
|
| 2013 |
Galili U. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology. 140: 1-11. PMID 23578170 DOI: 10.1111/imm.12110 |
0.459 |
|
| 2013 |
Galili U. Discovery of the natural anti-Gal antibody and its past and future relevance to medicine. Xenotransplantation. 20: 138-47. PMID 23577774 DOI: 10.1111/xen.12034 |
0.46 |
|
| 2012 |
Hurwitz ZM, Ignotz R, Lalikos JF, Galili U. Accelerated porcine wound healing after treatment with α-gal nanoparticles. Plastic and Reconstructive Surgery. 129: 242e-251e. PMID 22286440 DOI: 10.1097/PRS.0b013e31823aebb1 |
0.366 |
|
| 2012 |
Galili U. Induced anti-non gal antibodies in human xenograft recipients. Transplantation. 93: 11-6. PMID 22146315 DOI: 10.1097/TP.0b013e31823be870 |
0.498 |
|
| 2011 |
Galili U. Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction. Clinical & Developmental Immunology. 2011: 134020. PMID 22162709 DOI: 10.1155/2011/134020 |
0.305 |
|
| 2010 |
Galili U, Albertini MR, Sondel PM, Wigglesworth K, Sullivan M, Whalen GF. In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids. Cancers. 2: 773-93. PMID 23087817 DOI: 10.3390/cancers2020773 |
0.359 |
|
| 2010 |
Galili U, Wigglesworth K, Abdel-Motal UM. Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction. Burns : Journal of the International Society For Burn Injuries. 36: 239-51. PMID 19501971 DOI: 10.1016/j.burns.2009.04.002 |
0.42 |
|
| 2009 |
Abdel-Motal UM, Wigglesworth K, Galili U. Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody. Vaccine. 27: 3072-82. PMID 19428921 DOI: 10.1016/j.vaccine.2009.03.019 |
0.364 |
|
| 2009 |
Abdel-Motal UM, Wigglesworth K, Galili U. Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity. Cancer Immunology, Immunotherapy : Cii. 58: 1545-56. PMID 19184002 DOI: 10.1007/s00262-009-0662-2 |
0.402 |
|
| 2008 |
Macher BA, Galili U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochimica Et Biophysica Acta. 1780: 75-88. PMID 18047841 DOI: 10.1016/j.bbagen.2007.11.003 |
0.567 |
|
| 2007 |
Galili U, Wigglesworth K, Abdel-Motal UM. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines. Journal of Immunology (Baltimore, Md. : 1950). 178: 4676-87. PMID 17372027 |
0.467 |
|
| 2007 |
Stone KR, Abdel-Motal UM, Walgenbach AW, Turek TJ, Galili U. Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation Transplantation. 83: 211-219. PMID 17264818 DOI: 10.1097/01.tp.0000250598.29377.13 |
0.419 |
|
| 2006 |
Ogawa H, Galili U. Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay. Glycoconjugate Journal. 23: 663-74. PMID 17115279 DOI: 10.1007/s10719-006-9005-0 |
0.451 |
|
| 2006 |
Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 35: 45-58. PMID 16905361 DOI: 10.1016/j.transci.2006.05.007 |
0.555 |
|
| 2006 |
Abdel-Motal U, Wang S, Lu S, Wigglesworth K, Galili U. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes. Journal of Virology. 80: 6943-51. PMID 16809300 DOI: 10.1128/JVI.00310-06 |
0.366 |
|
| 2005 |
Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunology and Cell Biology. 83: 674-86. PMID 16266320 DOI: 10.1111/j.1440-1711.2005.01366.x |
0.518 |
|
| 2005 |
Manches O, Plumas J, Lui G, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Galili U. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells. Haematologica. 90: 625-34. PMID 15921377 |
0.321 |
|
| 2005 |
Deriy L, Ogawa H, Gao GP, Galili U. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1, 3galactosyltransferase gene Cancer Gene Therapy. 12: 528-539. PMID 15818383 DOI: 10.1038/sj.cgt.7700812 |
0.343 |
|
| 2004 |
Galili U. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens. Transplantation. 78: 1093-8. PMID 15502700 |
0.484 |
|
| 2004 |
Ogawa H, Mohiuddin MM, Yin DP, Shen J, Chong AS, Galili U. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation. 77: 366-73. PMID 14966409 DOI: 10.1097/01.TP.0000109276.57772.6D |
0.377 |
|
| 2004 |
Ogawa H, Yin DP, Galili U. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene. Gene Therapy. 11: 292-301. PMID 14737089 DOI: 10.1038/sj.gt.3302178 |
0.444 |
|
| 2003 |
Galili U, Chen ZC, DeGeest K. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine. Gynecologic Oncology. 90: 100-8. PMID 12821349 |
0.376 |
|
| 2003 |
Mohiuddin MM, Ogawa H, Yin DP, Galili U. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells. Blood. 102: 229-36. PMID 12649147 DOI: 10.1182/blood-2002-11-3515 |
0.408 |
|
| 2003 |
Mohiuddin MM, Ogawa H, Yin DP, Shen J, Galili U. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation. 75: 258-62. PMID 12589143 DOI: 10.1097/01.TP.0000053616.61907.D5 |
0.386 |
|
| 2003 |
Ogawa H, Yin DP, Shen J, Galili U. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen. Blood. 101: 2318-20. PMID 12406874 DOI: 10.1182/blood-2002-07-2151 |
0.436 |
|
| 2002 |
Galili U, Ishida H, Tanabe K, Toma H. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts. Transplantation. 74: 1574-80. PMID 12490791 DOI: 10.1097/01.TP.0000038524.28093.38 |
0.544 |
|
| 2002 |
Tanemura M, Ogawa H, Yin DP, Chen ZC, DiSesa VJ, Galili U. Elimination of anti-Gal B cells by alpha-Gal ricin1. Transplantation. 73: 1859-68. PMID 12131678 |
0.516 |
|
| 2002 |
Deriy L, Chen ZC, Gao GP, Galili U. Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA. Glycobiology. 12: 135-44. PMID 11886847 DOI: 10.1093/GLYCOB/12.2.135 |
0.386 |
|
| 2002 |
Galili U. The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie. 83: 557-63. PMID 11522383 DOI: 10.1016/S0300-9084(01)01294-9 |
0.39 |
|
| 2002 |
Galili U, Chen ZC, Manches O, Plumas J, Preisler H. Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes. Journal of Hematotherapy & Stem Cell Research. 10: 501-11. PMID 11522233 DOI: 10.1089/15258160152509118 |
0.336 |
|
| 2001 |
Chen ZC, Tanemura M, Galili U. Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris. Glycobiology. 11: 577-86. PMID 11447137 DOI: 10.1093/GLYCOB/11.7.577 |
0.416 |
|
| 2001 |
Tanemura M, Yin D, DiSesa VJ, Galili U. Preventing anti-Gal response in xenograft recipients by an alpha-Gal toxin. Transplantation Proceedings. 33: 699-700. PMID 11267025 DOI: 10.1016/S0041-1345(00)02210-7 |
0.435 |
|
| 2001 |
Galili U, Chen Z, Tanemura M, Seregina T, Link CJ. Understanding the Induced Antibody Response Graft. 4: 32-35. DOI: 10.1177/152216280100400108 |
0.381 |
|
| 2001 |
Galili U. Preformed and elicited antibodies to pig antigens in nonhuman primates and humans Current Opinion in Organ Transplantation. 6: 30-35. DOI: 10.1097/00075200-200103000-00006 |
0.418 |
|
| 2000 |
Chen ZC, Radic MZ, Galili U. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice. Molecular Immunology. 37: 455-66. PMID 11090880 DOI: 10.1016/S0161-5890(00)00064-X |
0.536 |
|
| 2000 |
Tanemura M, Galili U. T cells interacting with the alpha-Gal epitope: studies in alpha1, 3Galactosyltransferase knock-out mice. Transplantation Proceedings. 32: 921-3. PMID 10936273 DOI: 10.1016/S0041-1345(00)01037-X |
0.333 |
|
| 2000 |
Tanemura M, Galili U. Identification of B cells with receptors for alpha-Gal epitopes (Galalpha 1-3Galbeta1-4GlcNac-R) in xenograft recipients. Transplantation Proceedings. 32: 857-8. PMID 10936243 DOI: 10.1016/S0041-1345(00)01009-5 |
0.314 |
|
| 2000 |
Chen ZC, Galili U. Genes coding for anti-Gal in knock-out mice for the alpha1, 3Galactosyltransferase gene: analysis by hybridomas. Transplantation Proceedings. 32: 846-7. PMID 10936238 DOI: 10.1016/S0041-1345(00)01004-6 |
0.378 |
|
| 2000 |
Tanemura M, Galili U. Differential expression of alpha-Gal epitopes on pig and mouse organs. Transplantation Proceedings. 32: 843. PMID 10936236 DOI: 10.1016/S0041-1345(00)01002-2 |
0.353 |
|
| 2000 |
Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. The Journal of Clinical Investigation. 105: 301-10. PMID 10675356 DOI: 10.1172/JCI7358 |
0.502 |
|
| 2000 |
Tanemura M, Maruyama S, Galili U. Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation. 69: 187-90. PMID 10653403 DOI: 10.1097/00007890-200001150-00034 |
0.403 |
|
| 2000 |
Maruyama S, Cantu E, Galili U, D'agati V, Godman G, Stern DM, Andres G. α-Galactosyl epitopes on glycoproteins of porcine renal extracellular matrix Kidney International. 57: 655-663. PMID 10652044 DOI: 10.1046/J.1523-1755.2000.00887.X |
0.471 |
|
| 2000 |
Tanemura M, Yin T, Chong AS, Galili U. ANTI-CD40L TRANSIENTLY SUPPRESSES PRODUCTION OF ANTI-GAL IgG BUT NOT IgM IN α1,3GALACTOSYLTRANSFERASE KNOCK-OUT MICE IMMUNIZED WITH PIG KIDNEY MEMBRANES. Transplantation. 69: S150. DOI: 10.1097/00007890-200004271-00143 |
0.321 |
|
| 1999 |
Maruyama S, Cantu E, DeMartino C, Wang CY, Chen J, Al-Mohanna F, Nakeeb SM, D'Agati V, Pernis B, Galili U, Godman G, Stern DM, Andres G. Interaction of baboon anti-alpha-galactosyl antibody with pig tissues. The American Journal of Pathology. 155: 1635-49. PMID 10550320 DOI: 10.1016/S0002-9440(10)65479-X |
0.576 |
|
| 1999 |
Maruyama S, Cantu E3rd, Pernis B, Galili U, Godman G, Stern DM, Andres G. Alpha-galactosyl antibody redistributes alpha-galactosyl at the surface of pig blood and endothelial cells. Transplant Immunology. 7: 101-6. PMID 10544440 DOI: 10.1016/S0966-3274(99)80026-4 |
0.606 |
|
| 1999 |
Rother RP, Galili U. alpha-Gal epitopes on viral glycoproteins. Sub-Cellular Biochemistry. 32: 143-72. PMID 10391995 DOI: 10.1007/978-1-4615-4771-6_7 |
0.382 |
|
| 1999 |
Galili U, Wang L, LaTemple DC, Radic MZ. The natural anti-Gal antibody. Sub-Cellular Biochemistry. 32: 79-106. PMID 10391992 DOI: 10.1007/978-1-4615-4771-6_4 |
0.517 |
|
| 1999 |
Galili U. Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope. Sub-Cellular Biochemistry. 32: 1-23. PMID 10391989 DOI: 10.1007/978-1-4615-4771-6_1 |
0.354 |
|
| 1999 |
Galili U. Significance of anti-Gal IgG in chronic xenograft rejection. Transplantation Proceedings. 31: 940-1. PMID 10083416 DOI: 10.1016/S0041-1345(98)01846-6 |
0.349 |
|
| 1999 |
Galili U, Tanemura M. Significance of .ALPHA.-Gal (Gal.ALPHA.1-3Gal.BETA.1-4GlcNAc-R) Epitopes and .ALPHA.1,3 Galactosyltransferase in Xenotransplantation. Trends in Glycoscience and Glycotechnology. 11: 317-327. DOI: 10.4052/TIGG.11.317 |
0.341 |
|
| 1998 |
LaTemple DC, Galili U. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation. 5: 191-196. PMID 9741457 DOI: 10.1111/J.1399-3089.1998.Tb00027.X |
0.551 |
|
| 1998 |
Stone KR, Ayala G, Goldstein J, Hurst R, Walgenbach A, Galili U. Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of α-galactosidase-treated porcine cartilage Transplantation. 65: 1577-1583. PMID 9665073 DOI: 10.1097/00007890-199806270-00007 |
0.419 |
|
| 1998 |
Galili U, LaTemple DC, Radic MZ. A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation. 65: 1129-32. PMID 9583877 DOI: 10.1097/00007890-199804270-00020 |
0.601 |
|
| 1998 |
Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation. 65: 971-8. PMID 9565103 DOI: 10.1097/00007890-199804150-00018 |
0.465 |
|
| 1998 |
Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. Transplantation. 65: 844-53. PMID 9539098 DOI: 10.1097/00007890-199803270-00013 |
0.474 |
|
| 1997 |
Wang L, Radic MZ, Siegel D, Chang T, Bracy J, Galili U. Cloning of anti-Gal Fabs from combinatorial phage display libraries: structural analysis and comparison of Fab expression in pComb3H and pComb8 phage. Molecular Immunology. 34: 609-18. PMID 9393964 DOI: 10.1016/S0161-5890(97)00082-5 |
0.48 |
|
| 1997 |
Henion TR, Gerhard W, Anaraki F, Galili U. Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody. Vaccine. 15: 1174-82. PMID 9286041 DOI: 10.1016/S0264-410X(96)00300-3 |
0.492 |
|
| 1997 |
Shinkel TA, Chen CG, Salvaris E, Henion TR, Barlow H, Galili U, Pearse MJ, d'Apice AJ. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation. 64: 197-204. PMID 9256173 DOI: 10.1097/00007890-199707270-00003 |
0.409 |
|
| 1997 |
Galili U, LaTemple DC. Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity Immunology Today. 18: 281-285. PMID 9190114 DOI: 10.1016/S0167-5699(97)80024-2 |
0.371 |
|
| 1997 |
Galili U, LaTemple DC, Walgenbach AW, Stone KR. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection Transplantation. 63: 646-651. PMID 9075832 DOI: 10.1097/00007890-199703150-00006 |
0.465 |
|
| 1997 |
Galili U, Minanov OP, MlchSer RE, Stone KR. High‐affinity anti‐Gal immunoglobulin G in chronic rejection of xenografts Xenotransplantation. 4: 127-131. DOI: 10.1111/J.1399-3089.1997.Tb00175.X |
0.51 |
|
| 1996 |
Pothoulakis C, Galili U, Castagliuolo I, Kelly CP, Nikulasson S, Dudeja PK, Brasitus TA, LaMont JT. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology. 110: 1704-12. PMID 8964394 DOI: 10.1053/GAST.1996.V110.PM8964394 |
0.446 |
|
| 1996 |
Teneberg S, Lönnroth I, Torres López JF, Galili U, Halvarsson MO, Angström J, Karlsson KA. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology. 6: 599-609. PMID 8922955 DOI: 10.1093/GLYCOB/6.6.599 |
0.453 |
|
| 1996 |
Galili U, Matta KL. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides Transplantation. 62: 256-262. PMID 8755825 DOI: 10.1097/00007890-199607270-00018 |
0.62 |
|
| 1996 |
Galili U, Repik PM, Anaraki F, Mozdzanowska K, Washko G, Gerhard W. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody. Vaccine. 14: 321-8. PMID 8744560 DOI: 10.1016/0264-410X(95)00189-8 |
0.598 |
|
| 1995 |
Galili U, Anaraki F. α-Galactosyl (Galα1-3Galβ1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate α1,3galactosyltransferase expressed in E.coli Glycobiology. 5: 775-782. PMID 8720075 DOI: 10.1093/Glycob/5.8.775 |
0.575 |
|
| 1995 |
Hamadeh RM, Galili U, Zhou P, Griffiss JM. Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clinical and Diagnostic Laboratory Immunology. 2: 125-31. PMID 7697518 DOI: 10.1128/cdli.2.2.125-131.1995 |
0.519 |
|
| 1995 |
Wang L, Anaraki F, Henion TR, Galili U. Variations in Activity of the Human Natural Anti-Gal Antibody in Young and Elderly Populations Journals of Gerontology Series a-Biological Sciences and Medical Sciences. 50. PMID 7542151 DOI: 10.1093/Gerona/50A.4.M227 |
0.566 |
|
| 1995 |
Galili U, Gregory CR, Morris RE. Contribution of anti-gal to primate and human IgG binding to porcine endothelial cells$ Transplantation. 60: 210-213. DOI: 10.1097/00007890-199507000-00019 |
0.441 |
|
| 1995 |
Galili U, Andrews P. Suppression of α-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: a major evolutionary event in ancestral Old World primates Journal of Human Evolution. 29: 433-442. DOI: 10.1006/Jhev.1995.1067 |
0.476 |
|
| 1994 |
Kim M, Rao MV, Tweardy DJ, Prakash M, Galili U, Gorelik E. Lectin-induced apoptosis of tumour cells. Glycobiology. 3: 447-53. PMID 8286857 DOI: 10.1093/GLYCOB/3.5.447 |
0.317 |
|
| 1994 |
Henion TR, Macher BA, Anaraki F, Galili U. Defining the minimal size of catalytically active primate α1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme Glycobiology. 4: 193-202. PMID 8054718 DOI: 10.1093/Glycob/4.2.193 |
0.448 |
|
| 1994 |
Repik PM, Strizki JM, Galili U. Differential Host-dependent Expression of α-galactosyl Epitopes on Viral Glycoproteins: A Study of Eastern Equine Encephalitis Virus as a Model Journal of General Virology. 75: 1177-1181. PMID 7513744 DOI: 10.1099/0022-1317-75-5-1177 |
0.42 |
|
| 1994 |
Galili U. A SIMPLE GENERAL METHOD FOR OPSONIZATION OF HUMAN AUTOLOGOUS TUMOR VACCINES BY THE NATURAL ANTI-GAL ANTIBODY Journal of Immunotherapy. 16: 236. DOI: 10.1097/00002371-199410000-00017 |
0.326 |
|
| 1993 |
Gorelik E, Kim M, Duty L, Henion T, Galili U. Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms. Clinical & Experimental Metastasis. 11: 439-452. PMID 8222393 DOI: 10.1007/Bf00054935 |
0.376 |
|
| 1993 |
Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans Immunology Today. 14: 480-482. PMID 7506033 DOI: 10.1016/0167-5699(93)90261-I |
0.526 |
|
| 1993 |
Galili U. Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody Springer Seminars in Immunopathology. 15: 155-171. PMID 7504839 DOI: 10.1007/Bf00201098 |
0.552 |
|
| 1993 |
Galili U, Anaraki F, Thall A, Hill-Black C, Radic M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody Blood. 82: 2485-2493. DOI: 10.1182/Blood.V82.8.2485.Bloodjournal8282485 |
0.621 |
|
| 1992 |
Galili U. The two antibody specificities within human anti-blood group B antibodies. Transfusion Medicine Reviews. 2: 112-21. PMID 2485158 DOI: 10.1016/S0887-7963(88)70037-1 |
0.442 |
|
| 1992 |
Thall A, Etienne-Decerf J, Winand RJ, Galili U. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells. Autoimmunity. 10: 81-7. PMID 1723633 DOI: 10.3109/08916939109004811 |
0.506 |
|
| 1992 |
Galili U, Ron M, Sharon R. The natural anti-alpha-galactosyl IgG in seminal fluid. A simple means to determine damage to the blood-genital tract barrier in infertile males. Journal of Immunological Methods. 151: 117-22. PMID 1629603 DOI: 10.1016/0022-1759(92)90109-7 |
0.502 |
|
| 1992 |
Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffiss JM. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. The Journal of Clinical Investigation. 89: 1223-35. PMID 1556184 DOI: 10.1172/JCI115706 |
0.406 |
|
| 1991 |
Galili U, Swanson K. Gene sequences suggest inactivation of α-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys Proceedings of the National Academy of Sciences of the United States of America. 88: 7401-7404. PMID 1908095 DOI: 10.1073/PNAS.88.16.7401 |
0.309 |
|
| 1991 |
Thall A, Etienne-Decerf J, Winand RJ, Galili U. The alpha-galactosyl epitope on mammalian thyroid cells. Acta Endocrinologica. 124: 692-9. PMID 1712528 DOI: 10.1530/ACTA.0.1240692 |
0.485 |
|
| 1991 |
Sorette M, Galili U, Clark M. Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells Blood. 77: 628-636. DOI: 10.1182/BLOOD.V77.3.628.628 |
0.522 |
|
| 1990 |
Thall A, Galili U. Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry. 29: 3959-65. PMID 2354167 DOI: 10.1021/BI00468A024 |
0.438 |
|
| 1989 |
Galili U. Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes? Lancet (London, England). 2: 358-61. PMID 2474731 DOI: 10.1016/S0140-6736(89)90539-4 |
0.512 |
|
| 1988 |
Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infection and Immunity. 56: 1730-7. PMID 3290105 DOI: 10.1128/iai.56.7.1730-1737.1988 |
0.573 |
|
| 1987 |
Buehler J, Galili U, Macher BA. Use of the enzyme-linked immunoadsorbent assay to monitor the purification of glycosphingolipid antigens by high-performance liquid chromatography. Analytical Biochemistry. 164: 521-5. PMID 3479028 DOI: 10.1016/0003-2697(87)90527-6 |
0.322 |
|
| 1987 |
Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proceedings of the National Academy of Sciences of the United States of America. 84: 1369-73. PMID 2434954 DOI: 10.1073/PNAS.84.5.1369 |
0.585 |
|
| 1987 |
Galili U, Buehler J, Shohet SB, Macher BA. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. The Journal of Experimental Medicine. 165: 693-704. PMID 2434599 DOI: 10.1084/JEM.165.3.693 |
0.574 |
|
| 1987 |
Galili U, Basbaum C, Shohet S, Buehler J, Macher B. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. Journal of Biological Chemistry. 262: 4683-4688. DOI: 10.1016/s0021-9258(18)61249-9 |
0.561 |
|
| 1986 |
Galili U, Flechner I, Knyszynski A, Danon D, Rachmilewitz EA. The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. British Journal of Haematology. 62: 317-24. PMID 3947551 DOI: 10.1111/j.1365-2141.1986.tb02935.x |
0.533 |
|
| 1986 |
Galili U, Clark MR, Shohet SB. Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. The Journal of Clinical Investigation. 77: 27-33. PMID 3944254 DOI: 10.1172/JCI112286 |
0.567 |
|
| 1985 |
Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. The Journal of Experimental Medicine. 162: 573-82. PMID 2410529 DOI: 10.1084/JEM.162.2.573 |
0.567 |
|
| 1984 |
Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity Journal of Experimental Medicine. 160: 1519-1531. PMID 6491603 DOI: 10.1084/JEM.160.5.1519 |
0.515 |
|
| 1983 |
Galili U, Korkesh A, Kahane I, Rachmilewitz E. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells Blood. 61: 1258-1264. DOI: 10.1182/BLOOD.V61.6.1258.1258 |
0.422 |
|
| 1981 |
Galili U, Manny N, Izak G. EA rosette formation: a simple means to increase sensitivity of the antiglobulin test in patients with anti red cell antibodies. British Journal of Haematology. 47: 227-33. PMID 6937216 DOI: 10.1111/j.1365-2141.1981.tb02783.x |
0.333 |
|
| Show low-probability matches. |